A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease

L. Wain (Leicester, United Kingdom), N. Shrine (Leicester, United Kingdom), A. Guyatt (Leicester, United Kingdom), V. Jackson (Leicester, United Kingdom), A. Erzurumluoglu (Leicester, United Kingdom), C. Batini (Leicester, United Kingdom), N. Reeve (Leicester, United Kingdom), . Spirometa Consortium (Leicester, United Kingdom), . Lung Eqtl Study (Vancouver, Canada), B. Hobbs (Boston, MA, United States of America), M. Cho (Boston, MA, United States of America), D. Strachan (London, United Kingdom), A. Morris (Liverpool, United Kingdom), I. Hall (Nottingham, United Kingdom), M. Tobin (Leicester, United Kingdom)

Source: International Congress 2018 – Multiomics studies in epidemiology: what can they tell us?
Session: Multiomics studies in epidemiology: what can they tell us?
Session type: Oral Presentation
Number: 2188
Disease area: Airway diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Wain (Leicester, United Kingdom), N. Shrine (Leicester, United Kingdom), A. Guyatt (Leicester, United Kingdom), V. Jackson (Leicester, United Kingdom), A. Erzurumluoglu (Leicester, United Kingdom), C. Batini (Leicester, United Kingdom), N. Reeve (Leicester, United Kingdom), . Spirometa Consortium (Leicester, United Kingdom), . Lung Eqtl Study (Vancouver, Canada), B. Hobbs (Boston, MA, United States of America), M. Cho (Boston, MA, United States of America), D. Strachan (London, United Kingdom), A. Morris (Liverpool, United Kingdom), I. Hall (Nottingham, United Kingdom), M. Tobin (Leicester, United Kingdom). A weighted genetic risk score based on 279 signals of association with lung function predicts Chronic Obstructive Pulmonary Disease. 2188

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Distance estimation and functional distance perception in patients with Chronic Obstructive Lung Disease (COPD).
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Impact of abnormal body water distribution on prognostic of Chronic Obstructive Pulmonary Disease and heart failure patients.
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020

Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study
Source: International Congress 2017 – Markers of COPD progression
Year: 2017

Relationship between functional capacity, dynamic and static muscle function assessments in people with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018


The Alonnisos Study: Correlation of Chronic Obstructive Pulmonary Disease risk with demographic, habitual and dietary factors in the general population of Alonnisos island
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021


Role of eosinopenia in predicting mortality and morbidity in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: International Congress 2019 – Airway diseases and blood cells
Year: 2019


The population risk attribution associated with chronic airway obstruction from the results of the Canadian Obstructive Lung Disease study.
Source: Virtual Congress 2021 – COPD burden, epidemiology and management
Year: 2021


Associations of gut microbiota and Chronic Obstructive Pulmonary Disease Assessment Test (CAT) score in chemotherapy treated lung cancer patients with COPD
Source: International Congress 2019 – Treatment of lung cancer
Year: 2019

Chronic Obstructive Pulmonary Disease (COPD) in patients of Chinese ethnicity reveal clinically relevant phenotypes
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Adaptive capacities and complexity of heart rate variability in patients with Chronic Obstructive Pulmonary Disease throughout pulmonary rehabilitation
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021


Dysfunctional breathing impacts symptom burden in Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020


Influence of global cardiovascular risk on health related quality of life  in patients with Chronic Obstructive Pulmonary Disease. Differences between frequent and infrequent exacerbator phenotype.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017


Comparing the Comorbidity burden in Chronic Obstructive Pulmonary Disease and Heart Failure : evidence from a large population cohort
Source: International Congress 2019 – More and more COPD
Year: 2019

Do GOLD stages of COPD severity really correspond to differences in health status?
Source: Eur Respir J 2003; 22: 444-449
Year: 2003



The role of Microalbuminuria as a predictor marker during acute exacerbations of Chronic Obstructive Pulmonary Disease
Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases
Year: 2021


Impact of concomitant cardiovascular diseases on functional status and quality of life of patients with Chronic Obstructive Pulmonary Diseases
Source: International Congress 2019 – From tobacco-related comorbidities to tobacco cessation
Year: 2019


Effect of smoking on the specific cholinergic hypersensitivity of airways in patients with Chronic Obstructive Pulmonary Disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 178s
Year: 2002

Pain is associated with balance and gait impairment in people with Chronic Obstructive Pulmonary Disease (COPD).
Source: Virtual Congress 2020 – A fresh look at the spectrum of symptoms in respiratory disease
Year: 2020


Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years
Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care
Year: 2018

“Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018